Abstract: There are provided measures for enabling/realizing support for idle period communication in semi-static channel access. Such measures exemplarily comprise that a user equipment device monitors for presence of a clearance indication provided by a base station device serving the user equipment device, which indicates clearance for communication by the user equipment device in at least one idle period of abase station device frame period, disables communication by the user equipment device in the at least one idle period of the base station device frame period when the monitoring yields absence of the clearance indication, and enables communication by the user equipment device in the at least one idle period of the base station device frame period when the monitoring yields presence of the clearance indication.

Abstract: A method to implement traceability and provability on a particular project in software development based on blockchain-recorded transactions of assigned developer time, the method comprising of the following steps: setting up a blockchain network comprised of a distributed, redundant, and tamper-resistant ledger; issuing each user an attestable pre-fabricated and signed virtualized environment on approved hardware that comes with functionality required for the user's role implemented as one of a set of virtual machine templates fashioned from a signed and approved pre-fabricated image; and verifying that assigned developer time is valid, and if so, record each development action on the ledger to enable extensive tracking and auditing of end-to-end software development process.

Abstract: An apparatus, provided in use in a first device comprises at least one processor and at least one memory including a computer program code, the at least one memory and computer program code configured to, with the at least one processor, cause the apparatus at least to: receive first information about a context provided by a controller, said first information being received from a base station; and cause the first device to transmit one or more ping messages to one or more second devices, said one or more ping messages comprising information about said context which causes one or more second devices to reply to the controller.

Abstract: An apparatus, method and computer program product for: performing channel availability monitoring on an operating channel for transmitting uplink control information for transmitting a data packet, in response to determining that the operating channel is available for transmitting the uplink control information, determining delay information relating to the channel availability monitoring, and transmitting the uplink control information and the delay information to the radio access network.

Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising therapeutic protein APC presentable antigens and immunosuppressants that provide tolerogenic immune responses specific to therapeutic proteins.

Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+ T cell help specific to an antigen.

Abstract: Binders, methods for making same, and methods for making composite lignocellulose products therefrom. The binder can include about 30 wt % to about 40 wt % of solids that include a urea-modified aldehyde-based resin; about 0.1 wt % to about 3 wt % of solids that include an isocyanate-based resin; about 0.1 wt % to about 12 wt % of an extender; and about 50 wt % to about 62 wt % of water, where all weight percent values are based on a total weight of the binder. The binder can have a sodium hydroxide equivalent weight alkalinity of about 3 wt % to about 9 wt %.

Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.

Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.

Abstract: This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.

Abstract: A transmitter is configured to set a counter to a starting value, sense whether a channel is busy or idle and to update the counter value during sensing. When there is data to be transmitted, the transmitter is configured to determine, based on at least the counter value at a transmit opportunity and a duration the channel has been sensed idle before the transmit opportunity, whether to transmit the data or to continue the sensing the channel to a next transmit opportunity without reset- ting the counter value to the starting value.

Abstract: A method to implement traceability and provability on a particular project in software development based on blockchain-recorded transactions of assigned developer time, the method comprising of the following steps: setting up a blockchain network comprised of a distributed, redundant, and tamper-resistant ledger; issuing each user an attestable pre-fabricated and signed virtualized environment on approved hardware that comes with functionality required for the user's role implemented as one of a set of virtual machine templates fashioned from a signed and approved pre-fabricated image; and verifying that assigned developer time is valid, and if so, record each development action on the ledger to enable extensive tracking and auditing of end- to-end software development process.

Abstract: Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.

Abstract: Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.

Abstract: There are provided measures for handling of paging messages in communication endpoint to network relaying scenarios.

Abstract: Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.

Abstract: Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.

Abstract: Methods and compositions related to intracellular delivery of gene editing proteins are provided. The invention relates to compositions and methods for transporting gene editing polypeptides, such as Cas9 or Cas12, into a cell ex vivo or in vivo. The invention includes a targeted active gene editing (TAGE) agent that includes an extracellular cell membrane binding moiety, e.g., an antigen binding polypeptide, a cell penetrating peptide (CPP), a ligand, or combinations thereof, that specifically binds to an extracellular cell membrane-bound molecule (e.g., a cell surface molecule), and a site-directed modifying polypeptide that recognizes a nucleic acid sequence. The extracellular cell membrane binding moiety (e.g.

Abstract: An apparatus, provided in use in a first device comprises at least one processor and at least one memory including a computer program code, the at least one memory and computer program code configured to, with the at least one processor, cause the apparatus at least to: receive first information about a context provided by a controller, said first information being received from a base station; and cause the first device to transmit one or more ping messages to one or more second devices, said one or more ping messages comprising information about said context which causes one or more second devices to reply to the controller.

Abstract: This invention relates to methods for reducing or preventing anaphylaxis to non-allergenic antigens with compositions comprising immunosuppressants, and related compositions.